For patient advocates, the passage of the Trump tax bill — signed into law on July 4 — was dispiriting and disappointing. #muliplesclerosis #chronicillness #medicaid #medicaidcuts #trumptaxbill #natio... TikTok video by Meredith O'Brien

For those in the #chronicillness community — I’m lookin’ at YOU, #mswarriors — the passage of the Trump tax bill has been mighty dispiriting. #multiplesclerosis #MS #reconciliationbill #trumptaxbill #medicaid #medicaidcuts #advocacy #healthcare #msactivist www.tiktok.com/t/ZP8hNEs2v/

Grateful for the opportunity to meet with @jayapal.house.gov’s office to discuss issues important to people living with MS. #MSActivist

Huge thanks to @repgwenmoore.bsky.social for rallying the #MSActivist room to “be bold” and tell our stories because “this is not a normal Hill day. 🧡

So grateful to @elliotwilliams.bsky.social for sharing his insight with #MSActivist at the Public Policy conference.

First clinical trial of MS remyelination therapy PTD802 cleared in... PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in multiple sclerosis.

This can't happen fast enough for me! #MSWarrior #MSActivist #MSRepair #Remyelination #MyelinRepair
multiplesclerosisnewstoday.com/news-posts/2...